Implementation Guide CH VACD
5.0.0-ci-build - ci-build Switzerland flag

Implementation Guide CH VACD, published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 5.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of and changes regularly. See the Directory of published versions

Example Bundle: Test Case C 01: Aggregated Dokument (RDD01)

Vaccination Record

Id: RDC01-Composition

Identifier: urn:ietf:rfc:3986#urn:uuid:20609dba-9f6a-4b94-bafa-0bad6839bf67

Status: Final

Code: Immunization record (

Patient: Patient/TC-patient Wegmueller Monika

Date: December 8, 2021


Patient/TC-patient Wegmueller Monika

Confidentiality: null Normal (qualifier value) (


Immunization Administration

Immunization Administration

Code: Hx of Immunization (



Additional Document Content

2. (Patient/TC-patient)

Anonymous Patient Female, DoB: 1967-02-10 ( Medical record number: 12345678)

3. (Practitioner/TC-HCP1-C1)

Generated Narrative: Practitioner

ResourcePractitioner "TC-HCP1-C1"

Profile: CH Core Practitioner EPR

identifier: GLN/7601888888884

active: true

name: Peter Müller

telecom: ph: tel:+, fax: fax:+,,

address: Grabenstrasse 2 Zürich 8005 CH

4. (Organization/TC-ORG1)

Generated Narrative: Organization

ResourceOrganization "TC-ORG1"

Profile: CH Core Organization EPR

identifier: GLN/7601777777718

name: Gruppenpraxis Müller


*ph: tel:+, fax: fax:+,, http://www.gruppenpraxis.chGrabenstrasse 2 Zürich ZH 8005 CH

5. (PractitionerRole/TC-HCP1-ORG1-ROLE-performer)

Generated Narrative: PractitionerRole

ResourcePractitionerRole "TC-HCP1-ORG1-ROLE-performer"

Profile: CH Core PractitionerRole EPR

active: true

practitioner: See on this page: Practitioner/TC-HCP1-C1

organization: See on this page: Organization/TC-ORG1

6. (Immunization/TCC01-IMMUN2-patient)

Generated Narrative: Immunization

ResourceImmunization "TCC01-IMMUN2-patient"

Profile: CH VACD Immunization

Author of the content: See on this page: Patient/TC-patient

CH VACD Extension Immunization Medication Reference: See on this page: Medication/TC-IMMUN-MEDIC-HAVRIX1440

identifier: urn:oid:2.16.756.


vaccineCode: Havrix 1440 (CH VACD Swissmedic Authorized Vaccines#558)

lotNumber: AHAVB946A

patient: See on this page: Patient/TC-patient

occurrence: 2021-06-02

route: Intramuscular use (


*See on this page: PractitionerRole/TC-HCP1-ORG1-ROLE-performer


*Viral hepatitis, type A (disorder) (SNOMED CT#40468003)

7. (Medication/TC-IMMUN-MEDIC-HAVRIX1440)

Generated Narrative: Medication

ResourceMedication "TC-IMMUN-MEDIC-HAVRIX1440"

Profile: CH VACD Medication For Immunization

identifier: urn:oid:2.16.756.

code: HAVRIX 1440 Inj Susp (unknown#7680005580054)

status: ACTIVE




8. (Organization/TC-ORG-GSK)

Generated Narrative: Organization

ResourceOrganization "TC-ORG-GSK"

Profile: CH Core Organization

identifier: GLN/7601001000674

name: GlaxoSmithKline AG


*ph: tel:+41 31 862 21 11(WORK), fax: fax:+41 31 862 22 00(WORK),, https://www.gsk.comTalstrasse 3-5 Münchenbuchsee BE 3053 CH